Key facts
- It has raised $53.7M across 3 recorded rounds; the latest was Seed Round ($2.7M) in Nov 2014.
- Notable investors include U.S. Department of Energy, JLS Fund.
- ProNova Solutions has filed 3 Form Ds with the SEC since 2012, most recently Nov 2014 ($2.7M sold to 12 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for ProNova Solutions
Funding rounds
3 roundsAbout ProNova Solutions
Developer of a compact proton therapy system designed to expand global access to advanced cancer treatment. The company's system offers a gantry technology, AI-enhanced treatment workflows, and multi-room expandability, enabling cancer treatment centers to improve clinical precision, reduce operational costs, and enhance patient experience.
- Sector
- Healthcare
- HQ
- Maryville, TN, United States
- Founded
- 2010
- Employees
- 82
- Website
- pronovasolutions.com/
- Ownership
- Privately Held (backing)
ProNova Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ProNova Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ProNova Solutions in its N-PORT filings yet. We sweep new filings monthly.